A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 9, 2006, Pages 490-497

  Heald, A ^a   Parr, C ^a   Gibson, C ^b   O'Driscoll, K ^a   Fowler, H ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cognition; Glucocorticoids; Pituitary adenoma

Indexed keywords

ADRENALECTOMY; ADULT; ARTICLE; ATTENTION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; INFORMATION PROCESSING; INTELLIGENCE QUOTIENT; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; MOOD DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PERCEPTION; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; TIME;

EID: 33845294351     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924332     Document Type: Article

References (26)

1. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-206
2. Coughlan AK. The Adult Memory and Information Processing Battery (AMIPB) Test Manual. Leeds, England: AK Coughlan, 1985
3. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001; 40: 337-434
4. Delis-DC, Kaplan E, Kramer JH, Ober BA. California Verbal Learning Test-Second UK Edition (CVLT-II). The Psychological Corporation, 2000
5. Dodrill CB. A neuropsychological battery for epilepsy. Epilepsia 1978; 19: 611-623
6. Forget H, Lacroix A, Cohen H. Persistent cognitive impairment follow-ing surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002; 27: 367-383
7. Grattan-Smith PJ, Morris JGL, Shores EA, Batchelor J, Sparks RS. Neuropsychological abnormalities in patients with pituitary tumours. Acta Neural Scand 1992; 86: 626-631
8. Guinan EM, Lowy C, Stanhope N, Lewis PDR, Kopelman MD. Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry 1998; 65: 870-876
9. Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol 2004; 61: 458-465
10. McCord M, Buatti J, Fennell E, Medenhall W, Marcus R, Rhoton A, Grant M, Friedman W. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. International J Radiation Oncol 1997; 39: 437-444
11. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G. Memory impairment in Cushing's disease. Acta Neurol Scand 1993; 87: 52-55
12. Nelson H, Wilson j. The National Adult Reading Test (NART) 1984. Nfer Nelson
13. Noad R, Narayanan K, Hewlett T, Lincoln N, Page R. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clinic Oncol 2004; 16: 233-237
14. Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE. Cognitive dysfunction in patients treated for pituitary tumours. J Clin Experimental Neuropsychol 1997; 19: 1-6
15. Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I. Test of Everyday Attention (TEA). Thames Valley Test Company, 1994
16. Ruddle HV, Bradshaw CM. On the estimation of premorbid intellectual functioning: validation of Nelson & McKenna's formula, and some new normative data. Br J Clin Psych 1982; 21: 159-165
17. Tombaugh TN, Rees L, McIntyre N. Normative data for the Trail Making Test. In: Spreen O, Strauss E (eds) (1998). Personal Communication. A compendium of neuropsychological tests. New York: Oxford University Press, 1988
18. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. NewYork: Oxford University Press, 1998
19. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's Syndrome. Arch Intern Med 1981; 141: 215-219
20. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biological Psychiatry 1992; 32: 756-765
21. Starkman MN, Giordani B, Berent S, Schork A, Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine 2001; 63: 985-993
22. Starkman MN, Giordani B, Gebarski SS, Schteingart DE. Improvement in learning associated with increase in hippocampal formation volume. Biological Psychiatry 2003; 53: 233-238
23. Surma-aho O, Niemela M, Vilkkij, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, Pyykkonen j, jaaskelainen j. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001; 56: 1285-1290
24. Warrington EK, James M. Visual Object and Space Perception Battery (VOSP). Thames Valley Test Company, 1991
25. Whelan TB, Schteingart DE, Starkman MD, Smith A. Neuropsycholog ical deficits in Cushing's Syndrome. j Nervous Mental Disease 1980; 168: 753-757
26. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Nfer Nelson, 1983